Overview

The Antidepressant Efficacy of the Anticholinergic Scopolamine

Status:
Terminated
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
A previous study showed that the intravenous administration of scopolamine produces antidepressant effects. This study is designed to determine if other routes of administration of scopolamine produce antidepressant effects.
Phase:
Phase 2
Details
Lead Sponsor:
National Institute of Mental Health (NIMH)
Treatments:
Antidepressive Agents
Butylscopolammonium Bromide
Cholinergic Antagonists
Scopolamine
Scopolamine Hydrobromide